Best wishes to All especially MF and MDS patients
Posted: Sat Dec 01, 2018 12:42 am
As we approach ASH, it is my sincerest hope that we will see strong meaningful positive data that will benefit patients. There is really not much to say as we await the updated data and see how the medical community evaluates and values it. Single agent activity is strong and in truth we know very little about combinations except in preclinical work. See you Monday night. bp